University of Colorado Southwest Oncology Group

描述(由申请人提供)：科罗拉多大学癌症中心(UCCC)请求继续支持作为成员机构参加西南肿瘤学小组(SWOG)。UCCC的使命是通过实验室和临床研究降低癌症发病率和死亡率。参与SWOG一直是这项使命不可或缺的一部分。UCCC的调查人员继续为SWOG的行政、教育和科学职能做出贡献。斯科特·比尔曼博士(首席调查员)、E·大卫·克劳福德和劳里·加斯帕是SWOG执行委员会理事会的成员。UCCC SWOG成员主持生殖泌尿(E.D.Crawford)和肺病理生物学(Wilbur Franklin)委员会。斯科特·卢西亚博士是前列腺癌预防试验(PCPT)诊断中心的主任。Lucia博士也是PCPT和硒和维生素E癌症预防试验(SELECT)指导委员会的成员。米歇尔·巴什博士于2002年被选为SWOG青年研究员。UCCC成员是1997-2002年赠款期间启动的有效SWOG方案中11%的协调人或共同协调人。此外，在UCCC进行的机构试点研究以前瞻性随机试验和全组第二阶段研究的形式提交给工作组。UCCC的研究人员在血液和骨髓移植、乳房、肺、放射治疗和GU委员会做出了重要贡献。预计新的教员将进一步增加参与，特别是在胃肠道委员会(S.Gail Ekerhardt和Michele Basche)和淋巴瘤委员会(John Sweetenham)。我们为我们对西南肿瘤学小组的贡献感到自豪，并致力于履行其使命。我们预计我们的西南肿瘤学小组的活动将在下一个赠款周期增加。

DESCRIPTION (provided by applicant): The University of Colorado Cancer Center (UCCC) requests continued support for participation in the Southwest Oncology Group (SWOG) as a member institution. The UCCC mission is the reduction of cancer incidence and mortality through laboratory and clinical research. Participation in SWOG has been an integral part of this mission. Investigators from the UCCC continue to contribute to the administrative, educational and scientific functions of SWOG. Drs. Scott Bearman (Principal Investigator), E. David Crawford, and Laurie Gaspar sit on the Board of Governors, SWOG's executive committee. UCCC SWOG members chair the Genitourinary (E.D. Crawford) and Lung Pathobiology (Wilbur Franklin) Committees. Dr. Scott Lucia serves as the director of the Diagnostic Center for the Prostate Cancer Prevention Trial (PCPT). Dr. Lucia is also a member of the steering committees for PCPT and Selenium and Vitamin E Cancer Prevention Trial (SELECT). Dr. Michele Basche was selected as a SWOG Young Investigator in 2002. UCCC members are coordinators or co-coordinators of 11% of active SWOG protocols activated during the 1997-2002 grant period. In addition, institutional pilot studies conducted at the UCCC have been brought to the Group in the form of prospective randomized trials and groupwide Phase II studies. UCCC investigators make important contributions to the Blood and Marrow Transplantation, Breast, Lung, Radiation Therapy and GU Committees. New faculty members are expected to increase participation further, particularly in the Gastrointestinal (S. Gail Eckhardt and Michele Basche) and Lymphoma (John Sweetenham) Committees. We are proud of our contributions to the Southwest Oncology Group and are committed to its mission. We expect our Southwest Oncology Group activities to increase in the next grant cycle.